The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3.

MLA

Kanai, Tomotake, et al. “The JNK Pathway Represents a Novel Target in the Treatment of Rheumatoid Arthritis through the Suppression of MMP-3.” Journal of Orthopaedic Surgery & Research, vol. 15, no. 1, July 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13018-020-01595-9.

APA

Kanai, T., Kondo, N., Okada, M., Sano, H., Okumura, G., Kijima, Y., Ogose, A., Kawashima, H., & Endo, N. (2020). The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3. Journal of Orthopaedic Surgery & Research, 15(1), 1–10. https://doi.org/10.1186/s13018-020-01595-9

Chicago

Kanai, Tomotake, Naoki Kondo, Masayasu Okada, Hiroshige Sano, Go Okumura, Yasufumi Kijima, Akira Ogose, Hiroyuki Kawashima, and Naoto Endo. 2020. “The JNK Pathway Represents a Novel Target in the Treatment of Rheumatoid Arthritis through the Suppression of MMP-3.” Journal of Orthopaedic Surgery & Research 15 (1): 1–10. doi:10.1186/s13018-020-01595-9.